| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Intellia Therapeutics, Inc.'s insiders have reduced their positions by a net 8,111 shares worth roughly $91K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), NTLA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.18M | - | |
| Dir | 207.5K | $2.49M | - | |
| CFO | 148.2K | $1.78M | -8,111 | |
| Dir | 134.7K | $1.62M | - | |
| VP | 121.2K | $1.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell | 31 | $17.38 | $538.78 | - | -51.7% | - | |
| Oct 1, 2025 | Dube Michael P45 | VP, Chief Accounting Officer | Sell | 1,871 | $17.38 | $32,517.98 | -3.3% | -51.7% | - | |
| Aug 20, 2025 | Chase William J | Director | Buy | 100,000 | $10.03 | $1,003,000.00 | +288.2% | -17.0% | - | |
| Jul 23, 2025 | Dulac Edward J III81 | EVP, Chief Financial Officer | Sell | 7,462 | $14.02 | $104,617.24 | -6.6% | +89.4% | - | |
| Jul 2, 2025 | Dube Michael P45 | VP, Chief Accounting Officer | Sell | 2,503 | $9.95 | $24,904.85 | -4.2% | +61.0% | +63.7% | |
| Jul 1, 2025 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 1,022 | $9.82 | $10,036.04 | -1.1% | +71.3% | +74.5% | |
| Jul 1, 2025 | Goodman Jesse | Director | Sell | 3,094 | $9.40 | $29,068.13 | -5.8% | +71.3% | +74.5% | |
| Apr 29, 2025 | Bhanji Muna57 | Director | Sell | 265 | $8.50 | $2,252.50 | -1.4% | +59.9% | - | |
| Mar 4, 2025 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 679 | $8.99 | $6,104.21 | -0.7% | -21.3% | +52.0% | |
| Mar 4, 2025 | Basta James72 | EVP, General Counsel | Sell | 2,572 | $8.99 | $23,122.28 | -2.2% | -21.3% | +52.0% |